Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials.
about
A "SMART" design for building individualized treatment sequencesExperimental design and primary data analysis methods for comparing adaptive interventions.Dynamic Treatment RegimesInference about the expected performance of a data-driven dynamic treatment regime.Expression of p21 protein predicts clinical outcome in DLBCL patients older than 60 years treated with R-CHOP but not CHOP: a prospective ECOG and Southwest Oncology Group correlative study on E4494.Inference for non-regular parameters in optimal dynamic treatment regimesInference for the median residual life function in sequential multiple assignment randomized trials.Introduction to SMART designs for the development of adaptive interventions: with application to weight loss research.A multiple imputation strategy for sequential multiple assignment randomized trialsSample size calculations for evaluating treatment policies in multi-stage designs.Introduction to dynamic treatment strategies and sequential multiple assignment randomization.Pattern-mixture-type Estimation and Testing of Neuroblastoma Treatment RegimesSMART designs in cancer research: Past, present, and future.Cumulative Hazard Ratio Estimation for Treatment Regimes in Sequentially Randomized Clinical TrialsEfficient design and inference for multistage randomized trials of individualized treatment policies.Innovative Clinical Trial Designs: Toward a 21st-Century Health Care SystemPrognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative studyDesigning a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy.Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer.Estimating the optimal dynamic antipsychotic treatment regime: Evidence from the sequential multiple assignment randomized CATIE Schizophrenia Study.Evaluating the Effect of Early Versus Late ARV Regimen Change if Failure on an Initial Regimen: Results From the AIDS Clinical Trials Group Study A5095.Adaptive Interventions in Child and Adolescent Mental HealthPersonalizing medicine: a review of adaptive treatment strategies.Comparing treatment policies with assistance from the structural nested mean model.Improve efficiency and reduce bias of Cox regression models for two-stage randomization designs using auxiliary covariates.Use of personalized Dynamic Treatment Regimes (DTRs) and Sequential Multiple Assignment Randomized Trials (SMARTs) in mental health studies.On Sparse representation for Optimal Individualized Treatment Selection with Penalized Outcome Weighted Learning.Comparing dynamic treatment regimes using repeated-measures outcomes: modeling considerations in SMART studies.Bayesian Dose-Finding in Two Treatment Cycles Based on the Joint Utility of Efficacy and Toxicity.Penalized Q-Learning for Dynamic Treatment RegimensEvaluating Joint Effects of Induction-Salvage Treatment Regimes on Overall Survival in Acute Leukemia.Using SMART design to improve symptom management among cancer patients: A study protocol.Estimation of the causal effects on survival of two-stage nonrandomized treatment sequences for recurrent diseases.Targeted maximum likelihood estimation for dynamic treatment regimes in sequentially randomized controlled trials.Dynamic treatment regimes for managing chronic health conditions: a statistical perspective.Up-front versus sequential randomizations for inference on adaptive treatment strategiesComparison of treatment regimes with adjustment for auxiliary variables
P2860
Q24619631-ADF47147-DF37-4558-A256-FBA0FCCB2B37Q30571530-2C431E73-F010-4C27-B5EE-21DFEBB511DDQ30597725-4D70FD45-13EE-4516-BECD-D6AC98CF4F9CQ30830842-92EFF4DE-B32B-4274-B716-87BD67B438F0Q33832087-D02CC510-C605-417C-87D7-A4CE806E5FB5Q33937413-AB412A68-5558-45A9-989F-04281B56F09FQ34127385-1E440100-A87D-4668-9A59-93D34F479C06Q34206856-02114E08-D725-4F4B-BF20-92C0F75F7311Q34287887-0383EF0F-7C2E-40E7-87B1-5F9B4B5334B2Q34393655-077C7F5E-E7AA-4197-B2F9-DAE020C2494CQ34437881-A9DCA17D-8294-4B3F-878F-F07BA343FDB3Q35149324-AA9EA22F-5A9F-417F-AA7F-32981BC65224Q35607162-4897B8D8-B9FB-4930-8E6C-DEA862ECF323Q35741333-C7F9B3E8-3A43-46F3-BF3A-30E35B1C095FQ35747106-6586A089-604F-40CA-A9DC-1BF37E9F9442Q35797280-2891F29E-B518-419B-9FFA-44337EA5A368Q35849663-0E7BEF76-C88E-48A2-8FE9-CC5D75D8650DQ36103577-F82B3A13-600B-4613-A10F-2D260FB6F6ECQ36206859-13705102-79D9-45E9-9C97-F6E55D17F469Q36330858-29A34FB9-D470-4854-89B7-2FA94B28F19FQ36534104-A277559D-4EF5-40DA-8265-04E32B99E39AQ37059108-93A7FFF6-45AF-4B6B-929A-E356690121DAQ38202081-97A0C41A-EDC3-45BF-A785-DD9ACE0711EAQ38957369-35DE09E2-3644-4611-9571-A8495027EA25Q38969245-86DC2A97-5F09-4062-9CA6-C72C3616B81DQ39044502-0770C587-F2E8-42F4-A154-0E9A701B566FQ39569323-23F7B2FF-1E17-4C38-BCEC-BE4936BB0AB7Q40240806-DF9A2DB3-C721-49D3-9916-A468A9E69BF0Q40543401-CC6C76CD-C8B8-4926-BC43-7D2A94F45E41Q40642766-D2C88F81-4896-481B-A5AA-8E15E9B000F8Q42103499-205AA142-C492-44B8-B164-E35BDECAA8E1Q47285491-B991B8DA-69AA-43A4-AD38-D34550C77FF9Q48430958-64939278-411D-4D76-9689-58BF5AD3E5C0Q51349968-7B57D95B-6F60-4560-A448-4F1A8318E8B0Q51895389-C79DAD3E-4505-4910-89BD-7D153EA61870Q57446489-9A683B7E-DCC3-46D3-85B2-FFBC4486799DQ57446495-FE1ACDD8-B056-4D1E-A520-4204ADEBDE8C
P2860
Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Optimal estimator for the surv ...... on designs in clinical trials.
@ast
Optimal estimator for the surv ...... on designs in clinical trials.
@en
Optimal estimator for the surv ...... on designs in clinical trials.
@nl
type
label
Optimal estimator for the surv ...... on designs in clinical trials.
@ast
Optimal estimator for the surv ...... on designs in clinical trials.
@en
Optimal estimator for the surv ...... on designs in clinical trials.
@nl
prefLabel
Optimal estimator for the surv ...... on designs in clinical trials.
@ast
Optimal estimator for the surv ...... on designs in clinical trials.
@en
Optimal estimator for the surv ...... on designs in clinical trials.
@nl
P1433
P1476
Optimal estimator for the surv ...... on designs in clinical trials.
@en
P2093
Anastasios A Tsiatis
P304
P356
10.1111/J.0006-341X.2004.00160.X
P407
P50
P577
2004-03-01T00:00:00Z